TABLE 3.

Association of smoking status with comorbidities in patients with AECOPD.

	Never-smoker (n = 200)	Ever-smoker (n = 834)	OR (95% CI)	P adj*
Hypertension	79 (39.5%)	269 (32.3%)	0.73 (0.53–1.00)	0.175
Heart failure	19 (9.5%)	69 (8.3%)	0.86 (0.50–1.46)	0.819
Atrial fibrillation	14 (7.0%)	42 (5.0%)	0.71 (0.38–1.32)	0.526
Coronary artery disease	25 (12.5%)	85 (10.2%)	0.79 (0.49–1.28)	0.633
Cardiac valve disease	14 (7.0%)	55 (6.6%)	0.93 (0.51–1.72)	0.901
Diabetes	20 (10.0%)	74 (8.9%)	0.88 (0.52–1.47)	0.819
Hyperlipidemia	13 (6.5%)	63 (7.6%)	1.17 (0.63–2.18)	0.819
Hyperuricemia	11 (5.5%)	51 (6.1%)	1.12 (0.57–2.19)	0.901
Hypoproteinemia	25 (12.5%)	90 (10.8%)	0.85 (0.53–1.36)	0.819
Bronchiectasis	18 (9.0%)	50 (6.0%)	0.64 (0.36–1.13)	0.328
Asthma	19 (9.5%)	82 (9.8%)	1.04 (0.61–1.75)	0.901
Tuberculosis	25 (12.5%)	116 (13.9%)	1.13 (0.71–1.80)	0.819
Chronic rhinitis	10 (5.0%)	61 (7.3%)	1.49 (0.75–2.98)	0.503
Lung cancer	1 (0.5%)	55 (6.6%)	14.1 (1.93–102.15)	<0.001
Other cancers	8 (4.0%)	42 (5.0%)	1.27 (0.58–2.75)	0.819

* p values are adjusted for multiple tests using the method Benjamini–Hochberg.